ICD-10-CM Billable Code

B45.2

Cutaneous cryptococcosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Cutaneous cryptococcosis is a fungal infection that affects the skin. It is caused by the Cryptococcus neoformans fungus, which can invade the skin either through direct contact or as a result of spread from other parts of the body. This condition is more common in individuals with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, or patients on immunosuppressive therapy. Recognizing the signs early can lead to appropriate medical attention and treatment.

Causes & Symptoms

Clinical Causes: Infection with the fungus Cryptococcus neoformans, which is found in environments like soil contaminated with bird droppings. Spread from a primary site of infection, such as the lungs or central nervous system, to the skin. Inhalation of fungal spores leading to systemic infection, especially in immunocompromised individuals. Trauma or skin breaks that allow the fungus to enter the skin.

Key Symptoms: Lesions on the skin that may appear as nodules, ulcers, or pustules. Swelling and redness around affected areas. Lesions may be painless or tender to the touch. In some cases, lesions can ulcerate or produce discharge. Other systemic symptoms may include fever, fatigue, or weight loss if the infection has spread.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical examination and laboratory investigations. Skin biopsy is often performed to examine tissue under a microscope, revealing the presence of the Cryptococcus fungus. Cultures from skin lesions can confirm the diagnosis. Additional tests such as blood cultures, chest X-rays, or lumbar punctures may be conducted if systemic involvement is suspected.

Treatment Protocols: Treatment generally involves antifungal medications, such as amphotericin B combined with flucytosine or fluconazole, depending on the severity and extent of the infection. Management of underlying immune deficiencies or conditions is also crucial. In some cases, surgical intervention might be necessary to remove affected tissue. Regular follow-up is important to monitor response to therapy and prevent recurrence.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B45.2 a billable ICD-10 code?
Yes, B45.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B45.2?
Clinical documentation must specify the nature of Cutaneous cryptococcosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

cutaneous cryptococcosis